Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics

Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness and fatiguability of skeletal muscles. It is an antibody-mediated disease, caused by autoantibodies targeting neuromuscular junction proteins. In the majority of patients (~85%) antibodies against the muscle acetylcholi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazaridis, Konstantinos, Tzartos, Socrates J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033452/
https://www.ncbi.nlm.nih.gov/pubmed/32117321
http://dx.doi.org/10.3389/fimmu.2020.00212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033452/
https://www.ncbi.nlm.nih.gov/pubmed/32117321
http://dx.doi.org/10.3389/fimmu.2020.00212

Ejemplares similares